Diabetes

The drug is indicated for use as a short-acting human insulin to improve glycemic control in adults and pediatric patients with diabetes mellitus. It is only intended to use in acute care settings under medical supervision.

Why does this woman have excessive facial and neck movements?

Retina Risk is a new app that patients can use to help screen for their risk of retinopathy.

The drug is earned the designation for reducing the risk of cardiovascular death and hospitalization for heart failure in people with chronic heart failure.

According to the CDC, approximately 1 of 3 patients with type 1 and 2 diabetes mellitus (DM) has CKD. What do we need to know about patients with DM and CKD?

Liraglutide is the first noninsulin drug approved to treat T2D in pediatric patients since metformin was approved for pediatric use in 2000, according to the FDA.

Officials with the FDA today approved liraglutide (Victoza, Novo Nordisk) injection for treatment of pediatric patients age 10 years or older with type 2 diabetes (T2D).

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new subgroup analysis from the phase 3 CREDENCE study,

Top news of the day from across the health care landscape.

Data from 2 studies noted no differences between either program.

Researchers did not find a statistically significant benefit in using vitamin D to decrease the likelihood of developing type 2 diabetes in high risk individuals.

Topical insulin helps acinar cells proliferate and speeds the repair and healing of the lacrimal gland by stimulating the insulin-like growth factor-1 receptor (IGF-1R).

They are accessible to patients, help identify risk factors, provide lifestyle education, and offer medication management.

With a cohort of approximately 50,000, this may be the largest exome sequencing study of type 2 diabetes.

Top news of the day from across the health care landscape.

Uncontrolled diabetes in pregnancy can lead to preeclampsia, cesarean delivery, preterm delivery, significant overgrowth in the child, and congenital defects.

Top news of the day from across the health care landscape.

Dapagliflozin is a selective sodium‑glucose cotransporter-2 (SGLT-2) inhibitor that is combined with a dipeptidyl peptidase‑4 (DPP‑4) inhibitor, saxagliptin; and metformin hydrochloride extended release.

Officials with the FDA have approved AstraZeneca’s dapagliflozin, saxagliptin and metformin hydrochloride (Qternmet XR) extended release tablets for adults with type 2 diabetes.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Novo Nordisk announced the results of the ELLIPSE trial, which examined efficacy and safety and demonstrated superiority of liraglutide (Victoza) injection 1.8 mg vs placebo, in a presentation at the Pediatric Endocrine Society (PES)/Pediatric Academic Societies (PAS) Annual Meeting in Baltimore, MD, on Sunday.

Manufacturers file challenge in court resulting in compromise between state government and pharmaceutical companies.

Antioxidants can be used to improve certain health conditions.

Top news of the day from across the health care landscape.

They cover considerations for planning and executing strategies for patients and coordinating MTM with local pharmacies.

A study, which tested naturally occurring homoisoflavonoids found in the Hyacinthaceae plant family and their synthetic derivatives, focused on the abnormal growth of new blood vessel cells in the eye that are linked to types of blindness.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The expansion of the Valyou Savings Program helps to address the challenge many patients face regarding unpredictable and unaffordable pricing for their insulin, according to the company.

Top news of the day from across the health care landscape.